In this edition:
– Dapagliflozin in acute HF
– ARNI vs. placebo in congenital systemic right ventricular HF
– Contemporary use and implications of β-blockers in HFMREF/HFPEF
– Managing iron deficiency in Asian HF patients
– β-blocker withdrawal and functional capacity improvement in HFPEF
– Phenotyping HF by genetics and associated conditions
– Impact of visit volume on effectiveness of electronic tools to improve HF care
– Pharmacological treatments in HFMREF/HFPEF
– Dementia risk with statins in HF
– Impact of rapid up-titration of GDMT on QOL in acute HF
Download the Heart Failure Research Review: Issue 86, with commentary by Dr Mark Nolan

